Surprisingly, despite the slight promoter inhibition, we found that in both the MCF7 and MDA-MB-231 cells, SR and CBD significantly inhibit Ser536 phosphorylation of NfKB, corroborating their anti-inflammatory activity in tumor cells (Figure 2A,B). The gene discussed is NFKB1; the disease is neoplasm.